Feedback / Questions
AGX-148 - AgonOx
PH-762 ACT - Phio Pharma
https://www.globenewswire.com/news-release/2023/08/21/2728590/0/en/Phio-Pharmaceuticals-Announces-Dosing-of-First-Patient-in-Collaborative-Clinical-Trial-with-AgonOx-Inc-and-Providence-Cancer-Institute.html
Aug 21, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next